✦ LIBER ✦

A Phase III, Randomized, Double-blind, Parallel-group, Placebo-controlled, Multicentre Study to Assess the Efficacy and Safety of the β3 Adrenoceptor Agonist, Mirabegron, in Patients With Symptoms of Overactive Bladder

✍ Scribed by Rovner, E.S.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Phase III, Randomized, Double-blind, P

✍ Herschorn, Sender; Barkin, Jack; Castro-Diaz, David; Frankel, Jeffrey M.; Espuna 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 407 KB

Randomized Double-blind, Active-controll

✍ Christopher R. Chapple; Steven A. Kaplan; David Mitcheson; Jiri Klecka; Jana Cum 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 508 KB

683 Randomised, double-blind, active-con

✍ C.R. Chapple; S. Kaplan; H.D. Mitcheson; J. Klecka; J. Cummings; T. Drogendijk; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 69 KB

Efficacy and safety of solifenacin succi

✍ Franklin Chu; Neila Smith; Takeshi Uchida 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 141 KB

A randomized double-blind placebo-contro

✍ Dudley Robinson; Linda Cardozo; Gerben Terpstra; John Bolodeoku; the Tamsulosin 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB

A Randomized, Double-Blind, Placebo-Cont

✍ Robert J. Weiss; Michael A. Weber; Albert A. Carr; Will A. Sullivan 📂 Article 📅 2007 🏛 Le Jacq Communications, Inc. 🌐 English ⚖ 218 KB